» Articles » PMID: 30135929

TBI-induced Nociceptive Sensitization is Regulated by Histone Acetylation

Overview
Journal IBRO Rep
Date 2018 Aug 24
PMID 30135929
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic pain after traumatic brain injury (TBI) is very common, but the mechanisms linking TBI to pain and the pain-related interactions of TBI with peripheral injuries are poorly understood. In these studies we pursued the hypothesis that TBI pain sensitization is associated with histone acetylation in the rat lateral fluid percussion model. Some animals received hindpaw incisions in addition to TBI to mimic polytrauma. Neuropathological analysis of brain tissue from sham and TBI animals revealed evidence of bleeding, breakdown of the blood brain barrier, in the cortex, hippocampus, thalamus and other structures related to pain signal processing. Mechanical allodynia was measured in these animals for up to eight weeks post-injury. Inhibitors of histone acetyltransferase (HAT) and histone deacetylase (HDAC) were used to probe the role of histone acetylation in such pain processing. We followed serum markers including glial fibrillary acidic protein (GFAP), neuron-specific enolase 2 (NSE) myelin basic protein (MBP) and S100β to gauge TBI injury severity. Our results showed that TBI caused mechanical allodynia in the hindpaws of the rats lasting several weeks. Hindpaws contralateral to TBI showed more rapid and profound sensitization than ipsilateral hindpaws. The inhibition of HAT using curcumin 50 mg/kg s.c reduced mechanical sensitization while the HDAC inhibitor suberoylanilide hydroxamic acid 50 mg/kg i.p. prolonged sensitization in the TBI rats. Immunohistochemical analyses of spinal cord tissue localized changes in the level of acetylation of the H3K9 histone mark to dorsal horn neurons. Taken together, these findings demonstrate that TBI induces sustained nociceptive sensitization, and changes in spinal neuronal histone proteins may play an important role.

Citing Articles

The analgesic effect of curcumin and nano-curcumin in clinical and preclinical studies: a systematic review and meta-analysis.

Hajimirzaei P, Eyni H, Razmgir M, Abolfazli S, Pirzadeh S, Ahmadi Tabatabaei F Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):393-416.

PMID: 39186190 DOI: 10.1007/s00210-024-03369-0.


Designer Receptor Exclusively Activated by Designer Drug (DREADD)-Mediated Activation of the Periaqueductal Gray Restores Nociceptive Descending Inhibition After Traumatic Brain Injury in Rats.

Irvine K, Shi X, Ferguson A, Clark J J Neurotrauma. 2024; 41(13-14):e1761-e1779.

PMID: 38588130 PMC: 11386998. DOI: 10.1089/neu.2024.0031.


Protective Effects of Plant-Derived Compounds Against Traumatic Brain Injury.

Khayatan D, Razavi S, Arab Z, Khanahmadi M, Samanian A, Momtaz S Mol Neurobiol. 2024; 61(10):7732-7750.

PMID: 38427213 PMC: 11415436. DOI: 10.1007/s12035-024-04030-w.


Emerging Neuroprotective Strategies: Unraveling the Potential of HDAC Inhibitors in Traumatic Brain Injury Management.

Ye L, Li W, Tang X, Xu T, Wang G Curr Neuropharmacol. 2024; 22(14):2298-2313.

PMID: 38288835 PMC: 11451322. DOI: 10.2174/1570159X22666240128002056.


Loss of diffuse noxious inhibitory control after traumatic brain injury in rats: A chronic issue.

Irvine K, Sahbaie P, Ferguson A, Clark J Exp Neurol. 2020; 333:113428.

PMID: 32745472 PMC: 11793995. DOI: 10.1016/j.expneurol.2020.113428.


References
1.
Langlois J, Rutland-Brown W, Wald M . The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil. 2006; 21(5):375-8. DOI: 10.1097/00001199-200609000-00001. View

2.
Sayer N, Cifu D, McNamee S, Chiros C, Sigford B, Scott S . Rehabilitation needs of combat-injured service members admitted to the VA Polytrauma Rehabilitation Centers: the role of PM&R in the care of wounded warriors. PM R. 2009; 1(1):23-8. DOI: 10.1016/j.pmrj.2008.10.003. View

3.
Patil S, Choudhary B, Rathore A, Roy K, Mahadik K . Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells. Phytomedicine. 2015; 22(12):1103-11. DOI: 10.1016/j.phymed.2015.08.006. View

4.
Mustafa G, Hou J, Tsuda S, Nelson R, Sinharoy A, Wilkie Z . Trigeminal neuroplasticity underlies allodynia in a preclinical model of mild closed head traumatic brain injury (cTBI). Neuropharmacology. 2016; 107:27-39. PMC: 8043235. DOI: 10.1016/j.neuropharm.2016.03.016. View

5.
Peddada K, Peddada K, Shukla S, Mishra A, Verma V . Role of Curcumin in Common Musculoskeletal Disorders: a Review of Current Laboratory, Translational, and Clinical Data. Orthop Surg. 2015; 7(3):222-31. PMC: 6583735. DOI: 10.1111/os.12183. View